Literature DB >> 12427968

Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.

Mei Qin1, Julia Kang, Carolyn Beebe Smith.   

Abstract

In humans, failure to express the fragile X mental retardation protein (FMRP) gives rise to fragile X syndrome, the most common form of inherited mental retardation. A fragile X knockout (fmr1 KO) mouse has been described that has some of the characteristics of patients with fragile X syndrome, including immature dendritic spines and subtle behavioral deficits. In our behavioral studies, fmr1 KO mice exhibited hyperactivity and a higher rate of entrance into the center of an open field compared with controls, suggesting decreased levels of anxiety. Our finding of impaired performance of fmr1 KO mice on a passive avoidance task is suggestive of a deficit in learning and memory. In an effort to understand what brain regions are involved in the behavioral abnormalities, we applied the [(14)C]deoxyglucose method for the determination of cerebral metabolic rates for glucose (CMR(glc)). We measured CMR(glc) in 38 regions in adult male fmr1 KO and WT littermates. We found CMR(glc) was higher in all 38 regions in fmr1 KO mice, and in 26 of the regions, differences were statistically significant. Differences in CMR(glc) ranged from 12% to 46%, and the greatest differences occurred in regions of the limbic system and primary sensory and posterior parietal cortical areas. Regions most affected are consistent with behavioral deficiencies and regions in which FMRP expression is highest. Higher CMR(glc) in fragile X mice may be a function of abnormalities found in dendritic spines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12427968      PMCID: PMC137789          DOI: 10.1073/pnas.242377399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Neuroanatomy of fragile X syndrome: the posterior fossa.

Authors:  A L Reiss; E Aylward; L S Freund; P K Joshi; R N Bryan
Journal:  Ann Neurol       Date:  1991-01       Impact factor: 10.422

2.  Regional cerebral glucose metabolism is normal in young adults with Down syndrome.

Authors:  M B Schapiro; C L Grady; A Kumar; P Herscovitch; J V Haxby; A M Moore; B White; R P Friedland; S I Rapoport
Journal:  J Cereb Blood Flow Metab       Date:  1990-03       Impact factor: 6.200

3.  Number and distribution of the apical dendritic spines of the layer V pyramidal cells in man.

Authors:  M Marin-Padilla
Journal:  J Comp Neurol       Date:  1967-12       Impact factor: 3.215

4.  Altered synaptic plasticity in a mouse model of fragile X mental retardation.

Authors:  Kimberly M Huber; Sean M Gallagher; Stephen T Warren; Mark F Bear
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

6.  Local cerebral glucose utilization in the autoimmune New Zealand black (NZB) mouse.

Authors:  A Wree; T Beck; G W Bielenberg; A Schleicher; K Zilles
Journal:  Histochemistry       Date:  1989

7.  Adult fragile X syndrome. Clinico-neuropathologic findings.

Authors:  R D Rudelli; W T Brown; K Wisniewski; E C Jenkins; M Laure-Kamionowska; F Connell; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Local cerebral glucose utilization in the free moving mouse: a comparison during two stages of the activity-rest cycle.

Authors:  T M Jay; M Jouvet; M H des Rosiers
Journal:  Brain Res       Date:  1985-09-09       Impact factor: 3.252

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Local cerebral glucose utilization in the adult cretinous rat.

Authors:  D Dow-Edwards; A M Crane; B Rosloff; C Kennedy; L Sokoloff
Journal:  Brain Res       Date:  1986-05-14       Impact factor: 3.252

View more
  47 in total

1.  Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.

Authors:  S M Goebel-Goody; E D Wilson-Wallis; S Royston; S M Tagliatela; J R Naegele; P J Lombroso
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

2.  Discrimination learning and attentional set formation in a mouse model of Fragile X.

Authors:  Kimberly S Casten; Annette C Gray; Rebecca D Burwell
Journal:  Behav Neurosci       Date:  2011-06       Impact factor: 1.912

3.  Comprehensive motor testing in Fmr1-KO mice exposes temporal defects in oromotor coordination.

Authors:  Snigdha Roy; Yu Zhao; Melody Allensworth; Mohamed F Farook; Mark S LeDoux; Lawrence T Reiter; Detlef H Heck
Journal:  Behav Neurosci       Date:  2011-10-17       Impact factor: 1.912

4.  Astrocytes prevent abnormal neuronal development in the fragile x mouse.

Authors:  Shelley Jacobs; Laurie C Doering
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

5.  Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.

Authors:  Wenzhong William Min; Christopher J Yuskaitis; Qijiang Yan; Christopher Sikorski; Shengqiang Chen; Richard S Jope; Robert P Bauchwitz
Journal:  Neuropharmacology       Date:  2008-10-14       Impact factor: 5.250

6.  A mouse model of the fragile X premutation: effects on behavior, dendrite morphology, and regional rates of cerebral protein synthesis.

Authors:  Mei Qin; Ali Entezam; Karen Usdin; Tianjian Huang; Zhong-Hua Liu; Gloria E Hoffman; Carolyn B Smith
Journal:  Neurobiol Dis       Date:  2011-01-08       Impact factor: 5.996

7.  Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice.

Authors:  M Qin; Z Xia; T Huang; C B Smith
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

8.  Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.

Authors:  Mei Qin; Zachary Zeidler; Kristen Moulton; Leland Krych; Zengyan Xia; Carolyn B Smith
Journal:  Behav Brain Res       Date:  2015-05-12       Impact factor: 3.332

9.  Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.

Authors:  Alexia M Thomas; Nghiem Bui; Deanna Graham; Jennifer R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Brain Res       Date:  2011-05-06       Impact factor: 3.332

Review 10.  Lithium: a promising treatment for fragile X syndrome.

Authors:  Zhonghua Liu; Carolyn Beebe Smith
Journal:  ACS Chem Neurosci       Date:  2014-05-15       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.